Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joschka Bartneck

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|September 20, 2023
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejectionAnn-Kathrin Hartmann, Joschka Bartneck, Jonas Pielenhofer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2023
Cross-presenting Langerhans cells are required for the early reactivation of resident CD8<sup>+</sup> memory T cells in the epidermisNadine Kamenjarin, Katrin Hodapp, Felix Melchior, et al.
Frontiers in Immunology|October 18, 2023
Tumor-infiltrating CCR2<sup>+</sup> inflammatory monocytes counteract specific immunotherapyJoschka Bartneck, Ann-Kathrin Hartmann, Lara Stein, et al.
NPJ Vaccines|September 24, 2022
Dithranol as novel co-adjuvant for non-invasive dermal vaccinationJulian Sohl, Ann-Kathrin Hartmann, Jennifer Hahlbrock, et al.
ACS Nano|February 1, 2022
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against TumorsJudith Stickdorn, Lara Stein, Danielle Arnold-Schild, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|September 20, 2023
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejectionAnn-Kathrin Hartmann, Joschka Bartneck, Jonas Pielenhofer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2023
Cross-presenting Langerhans cells are required for the early reactivation of resident CD8<sup>+</sup> memory T cells in the epidermisNadine Kamenjarin, Katrin Hodapp, Felix Melchior, et al.
Frontiers in Immunology|October 18, 2023
Tumor-infiltrating CCR2<sup>+</sup> inflammatory monocytes counteract specific immunotherapyJoschka Bartneck, Ann-Kathrin Hartmann, Lara Stein, et al.
NPJ Vaccines|September 24, 2022
Dithranol as novel co-adjuvant for non-invasive dermal vaccinationJulian Sohl, Ann-Kathrin Hartmann, Jennifer Hahlbrock, et al.
ACS Nano|February 1, 2022
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against TumorsJudith Stickdorn, Lara Stein, Danielle Arnold-Schild, et al.
Pageof 1